文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

放射治疗引起的肠道屏障损伤及修复过程——唾液代谢物差异与肠道屏障功能监测

Radiation therapy induced intestinal barrier damage and repair process - differences in salivary metabolites and monitoring of intestinal barrier function.

作者信息

Jingjing Zhang, Kun Wang, Yanyu Qiao, Mengjie Zhang, Yunqing Chen, Yulong Tian, Xuelong Jiao, Xiaojie Tan, Haitao Jiang, Feng Hou

机构信息

Department of Pathology Department, Affiliated Hospital of Qingdao University, Qingdao, China.

Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, China.

出版信息

Front Immunol. 2025 Jun 12;16:1590219. doi: 10.3389/fimmu.2025.1590219. eCollection 2025.


DOI:10.3389/fimmu.2025.1590219
PMID:40574858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197936/
Abstract

PURPOSE: Colorectal cancer (CRC) is still one of the most common malignant tumors, with gradual increase in its annual morbidity and mortality. But most cases are diagnosed in the late stage. For stage II-III cancer, clinical guidelines recommend surgery following neoadjuvant radiation therapy at ≥6 weeks after the last radiotherapy is completed. However, radiotherapy may impair intestinal mucosal barrier function, especially the biological and immune barriers, accompanied by perioperative complications. This study was conducted to investigate the changes, repair patterns, and potential mechanisms in patients after radiotherapy. METHODS: This study detected inflammatory factors in postoperative intestinal mucosal tissue and serum, as well as metabolites in saliva samples, and collected hematoxylin-eosin (HE)-stained pathological images in CRC patients who had received and did not receive radiotherapy. RESULTS: The results showed that after radiotherapy, there were significantly impaired intestinal mucosal tissue structure; obviously elevated inflammatory factors in intestinal mucosal tissue and blood; as well as upregulation/downregulation of metabolites in saliva samples. CONCLUSION: In conclusion, findings in this study may provide potential reference for predicting the recovery of intestinal mucosa and selecting the optimal timing for surgery after radiotherapy. In addition, this study will benefit the understanding and reduction of perioperative complications caused by intestinal barrier damage.

摘要

目的:结直肠癌(CRC)仍是最常见的恶性肿瘤之一,其年发病率和死亡率呈逐渐上升趋势。但大多数病例在晚期才被诊断出来。对于II - III期癌症,临床指南建议在完成最后一次放疗后≥6周进行新辅助放疗后再进行手术。然而,放疗可能会损害肠道黏膜屏障功能,尤其是生物和免疫屏障,并伴有围手术期并发症。本研究旨在调查放疗后患者的变化、修复模式及潜在机制。 方法:本研究检测了术后肠道黏膜组织和血清中的炎症因子,以及唾液样本中的代谢物,并收集了接受和未接受放疗的CRC患者的苏木精-伊红(HE)染色病理图像。 结果:结果显示,放疗后肠道黏膜组织结构明显受损;肠道黏膜组织和血液中的炎症因子明显升高;唾液样本中的代谢物上调/下调。 结论:总之,本研究结果可为预测肠道黏膜恢复及选择放疗后手术的最佳时机提供潜在参考。此外,本研究将有助于理解和减少肠道屏障损伤引起的围手术期并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/3c0241198fb8/fimmu-16-1590219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/67ec6feb4752/fimmu-16-1590219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/108187d9c71a/fimmu-16-1590219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/f8075cfe8054/fimmu-16-1590219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/3c0241198fb8/fimmu-16-1590219-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/67ec6feb4752/fimmu-16-1590219-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/108187d9c71a/fimmu-16-1590219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/f8075cfe8054/fimmu-16-1590219-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4d8/12197936/3c0241198fb8/fimmu-16-1590219-g004.jpg

相似文献

[1]
Radiation therapy induced intestinal barrier damage and repair process - differences in salivary metabolites and monitoring of intestinal barrier function.

Front Immunol. 2025-6-12

[2]
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Cochrane Database Syst Rev. 2020-10-19

[3]
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.

Eur J Cancer. 2007-1

[4]
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.

Cochrane Database Syst Rev. 2022-9-26

[5]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[6]
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.

Cochrane Database Syst Rev. 2022-5-20

[7]
Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy.

Cochrane Database Syst Rev. 2017-7-31

[8]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[9]
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.

Cochrane Database Syst Rev. 2018-7-9

[10]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

本文引用的文献

[1]
Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer.

Mol Cancer. 2024-9-13

[2]
Gingerenone A Attenuates Ulcerative Colitis via Targeting IL-17RA to Inhibit Inflammation and Restore Intestinal Barrier Function.

Adv Sci (Weinh). 2024-7

[3]
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2024

[4]
Dopamine receptor D2 confers colonization resistance via microbial metabolites.

Nature. 2024-4

[5]
[Cancer incidence and mortality in China, 2022].

Zhonghua Zhong Liu Za Zhi. 2024-3-23

[6]
The recovery of intestinal barrier function and changes in oral microbiota after radiation therapy injury.

Front Cell Infect Microbiol. 2023

[7]
TSP50 Attenuates DSS-Induced Colitis by Regulating TGF-β Signaling Mediated Maintenance of Intestinal Mucosal Barrier Integrity.

Adv Sci (Weinh). 2024-3

[8]
The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective.

Front Immunol. 2023

[9]
Research progress and treatment of radiation enteritis and gut microbiota.

Radiat Oncol J. 2023-6

[10]
Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.

Nutrients. 2023-5-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索